Genscript Biotech Corp (FRA:G51)
€ 1.66 0.1 (6.41%) Market Cap: 3.65 Bil Enterprise Value: 2.35 Bil PE Ratio: 0 PB Ratio: 2.89 GF Score: 68/100

Full Year 2022 Genscript Biotech Corp Earnings Presentation Transcript

Mar 30, 2023 / 11:30PM GMT
Release Date Price: €2.14
Unidentified Company Representative

Presentation
Mar 30, 2023 / 11:30PM GMT

=====================
Corporate Participants
=====================
* Brian Hosung Min
Genscript Biotech Corporation - CEO of Biologics Business
* Shiniu Wei
Genscript Biotech Corporation - CFO
* Weihui Shao
Genscript Biotech Corporation - CEO & COO

=====================
Conference Call Participants
=====================
* Jay Lee
Morningstar Inc., Research Division - Equity Analyst

=====================
-

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot